{"id":334552,"date":"2019-02-25T13:07:02","date_gmt":"2019-02-25T13:07:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=334552"},"modified":"2019-02-25T13:07:02","modified_gmt":"2019-02-25T13:07:02","slug":"pharma-cosmetics-2019-global-trends-market-size-share-status-swot-analysis-and-forecast-to-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharma-cosmetics-2019-global-trends-market-size-share-status-swot-analysis-and-forecast-to-2024_334552.html","title":{"rendered":"Pharma & Cosmetics 2019 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2024"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Pharma & Cosmetics Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyRerports.com Presents \u201cGlobal Pharma & Cosmetics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024\u201d New Document to its Studies Database<\/div>\n

 <\/p>\n

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body’s resistance to disease or to help diagnose diseases.<\/p>\n

Scope of the Report:
<\/strong>Pharmaceutical (OTC) occupies an important share in the pharmaceutical industry. Pharmaceuticals (OTC) can be classified into ointments, creams, gels and others according to drug properties.
Cosmetics can be classified into skincare, haircare, oral care and others according to application situations, of which skincare occupies the largest share.
The world pharma & cosmetics consuming market will still has a certain amount of growth. The world pharma & cosmetics<\/a><\/strong> production will increase at a growth rate of about 2.38%.
With the development of economy, the world pharma & cosmetics capacity will continue to expand in the future and the main consumption region will be in NA and EU.
The worldwide market for Pharma & Cosmetics is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 1924900 million US$ in 2024, from 1509500 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pharma & Cosmetics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.<\/p>\n

Market Segment by Manufacturers, this<\/strong> report covers
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L’ OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa<\/strong><\/p>\n

 <\/strong><\/p>\n

Request For Sample Report<\/strong> @ https:\/\/www.wiseguyreports.com\/sample-request\/3757923-global-pharma-cosmetics-market-2019-by-manufacturers-regions<\/a><\/p>\n

Market Segment by Regions<\/strong>, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)<\/p>\n

Market Segment by Type<\/strong>, covers
Ointments
Creams
Gels
Others<\/p>\n

Market Segment by Applications<\/strong>, can be divided into
Pharmaceuticals, OTC
Cosmetics<\/p>\n

 <\/strong><\/p>\n

Complete Report Details @ <\/strong>https:\/\/www.wiseguyreports.com\/reports\/3757923-global-pharma-cosmetics-market-2019-by-manufacturers-regions<\/a><\/p>\n

Table Of Contents:      <\/strong><\/p>\n

1 Market Overview
1.1 Pharma & Cosmetics Introduction
1.2 Market Analysis by Type
<\/strong>1.2.1 Ointments
1.2.2 Creams
1.2.3 Gels
1.2.4 Others
1.3 Market Analysis by Applications
<\/strong>1.3.1 Pharmaceuticals, OTC
1.3.2 Cosmetics
1.4 Market Analysis by Regions
<\/strong>1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
<\/strong>1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
<\/strong>2.1.1 Business Overview
2.1.2 Pharma & Cosmetics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
<\/strong>2.2.1 Business Overview
2.2.2 Pharma & Cosmetics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
<\/strong>2.3.1 Business Overview
2.3.2 Pharma & Cosmetics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
<\/strong>2.4.1 Business Overview
2.4.2 Pharma & Cosmetics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
<\/strong>2.5.1 Business Overview
2.5.2 Pharma & Cosmetics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly
<\/strong>2.6.1 Business Overview
2.6.2 Pharma & Cosmetics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 GSK
<\/strong>2.7.1 Business Overview
2.7.2 Pharma & Cosmetics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GSK Pharma & Cosmetics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)<\/p>\n

 Continued……<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Pharma & Cosmetics Market” WiseGuyRerports.com Presents \u201cGlobal Pharma & Cosmetics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024\u201d New Document to its Studies Database   Pharma is a substance of the prevention or treatment for human diseases. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-334552","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/334552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=334552"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/334552\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=334552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=334552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=334552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}